concentrated in vacuo to an aqueous concentrate (2 L) and
triethylamine added to adjust to pH ca. 8.5. This was passed
through four parallel C18 SPE cartridges (4 × 10 g, Varian HF
C18) followed by sequential elution with 50% H2O–MeOH (4 ×
40 mL each) and MeOH (4 × 40 mL each). The aqueous eluant
was adjusted to pH ca. 3.5 with the addition of trifluoroacetic acid
(TFA) and once more passed through the same C18 SPE cartridges
followed by similar sequential elution to afford 50% H2O–MeOH
and MeOH fractions. All 50% H2O–MeOH and MeOH eluants
were evaporated to give a combined residue (ca. 7.9 g). This was
subjected to preparative HPLC (60 mL min−1 with gradient elution
of 70 to 40% H2O–MeCN (0.01% TFA) over 20 min followed by
MeCN (0.01% TFA) for 10 min, through a 5 mm Phenomenex
Luna C18(2) 50 × 100 mm column), giving 10 fractions.
Dimethyl dicitrinin A (11). Dicitrinin A (5) (1.6 mg) was
dissolved in dry EtOAc (0.5 mL) after which Na2CO3 (10 mg)
and an excess of MeI (50 lL) were added, and the mixture stirred
overnight at 50 ◦C. The mixture was then filtered and evaporated
to dryness. Purification of the product was carried out using C8
HPLC (3.2 mL min−1 gradient elution from 60 to 30% H2O–
MeCN (0.1% TFA) over 20 min, through a 5 lm Zorbax C8 10 ×
250 mm column), to give dimethyl dicitrinin A (11) as a yellow
solid (1.1 mg, 64%). UV-vis kmax(EtOH)/nm 449 (e/dm3mol−1cm−1
830), 379 (6800), 306 (sh) (4100), 282 (7400), 208 (10400); UV-
vis kmax(EtOH–NaOH)/nm 299 (e/dm3mol−1cm−1 2600), 251 (sh)
(4600), 219 (19200); 1H NMR (d6-DMSO, 600 MHz) see Table 1;
13C NMR (d6-DMSO, 150 MHz) see Table 1; ESI(+)MS m/z
409 (M); HRESI(+)MS m/z 409.2012 (M, C25H29O5 requires
409.2015).
One of the combined fractions was partitioned between bu-
tanol and water, and the butanol-soluble material subjected to
preparative HPLC (22 mL min−1 gradient elution from 70 to 30%
H2O–MeCN over 16 min, through a 5 lm Zorbax RX–C8 21.2 ×
250 mm column) to yield citrinin (1) (130 mg) and dihydrocitrinin
(8) (9 mg). Another of the combined fractions was also partitioned
between butanol and water, and the water-soluble material further
purified by HPLC (2.5 mL min−1 gradient elution from 85 to
33% H2O–MeCN, through a 5 lm Zorbax StableBond C18 9.4 ×
250 mm column) to give phenol A acid 6 (6 mg).
Decomposition Studies
For the small scale “dilute” solution decompositions, the following
procedure was used. Two duplicate samples of citrinin (1) (10 mg)
were dissolved in aqueous MeOH (1 : 1, 4 mL) in vials, and a drop
of TFA added to one and TEA to the other. The vials were then
sealed and the mixture stirred at 50 ◦C for 4 d. Reaction progress
was monitored by LC-DAD-MS.
One of the more polar fractions was re-subjected to preparative
HPLC (60 mL min−1 with isocratic elution of 79% H2O–MeCN
(0.01% TFA) over 30 min, through a 5 lm Phenomenex Luna C18(2)
50 × 100 mm column), followed by C18 SPE (Alltech C18 Extract-
clean 2 g cartridge, 10% stepwise gradient elution from 80 to 100%
MeOH) to give dihydrocitrinone (7) (18 mg) and dicitrinin A (5)
(8 mg).
The small scale “concentrated” solution decompositions were
carried out in sealed vials. Three duplicate samples of citrinin (1)
(5 mg) were each dissolved in MeOH (100 lL) in vials. A drop of
TFA was added to one vial, a drop of TEA to another, and no
additive to the third. The sealed mixtures were heated at 50 ◦C for
15 d, and reaction progress monitored by LC-DAD-MS.
The large-scale decomposition was carried out in the same
manner, using 50 mg (0.2 mmol) of 1 in 0.5 mL MeOH, for
15 d. Fractionation of the products formed in the large-scale
decomposition was carried out using C18 HPLC (22 mL min−1
gradient elution from 20% H2O–MeCN (0.1% TFA) to MeCN
(0.1% TFA) over 30 min, through a 5 lm Zorbax StableBond-C18
21.2 × 250 mm column) to yield phenol A (2) (3.3 mg, 6.6%),
phenol A acid (6) (4.2 mg, 8.4%), and dicitrinin A (5) (8.0 mg,
16%) as the major products. A small quantity of unreacted citrinin
(1) (1.0 mg, 2%) was also recovered, while decarboxycitrinin (9)
(estimated 1.5 mg) was isolated but decomposed before analysis.
Three minor dimers, dicitrinin B (12) (0.8 mg, 1.6%), dicitrinin C
(13) (0.7 mg, 1.4%) and dicitrinin D (14) (0.9 mg, 1.8%) were also
isolated. UV-vis spectra for dicitrinins B–D were extracted from
DAD data-reported extinction coefficients are relative only.
Citrinin (1). Identified by spectroscopic analysis. [a]D,
ESI( )MS, 1H and 13C NMR were in good agreement with
literature values.8,14
Dicitrinin A (5). Red solid; [a]D +73.9◦ (c 0.016, CHCl3); IR
mmax(CHCl3)/cm−1 3495, 2985, 2932, 1618, 1533, 1455, 1411, 1381;
UV-vis kmax(EtOH)/nm 446 (sh) (e/dm3mol−1cm−1 7300), 422
(10500), 401 (sh) (8900), 304 (3400), 293 (sh) (4500), 276 (11100),
267 (11000), 223 (12100); UV-vis kmax(EtOH–HCl)/nm 490
(e/dm3mol−1cm−11300), 384 (9500), 309 (7600), 286 (8200), 245
(7200), 223 (9100), 208 (10400); UV-vis kmax(EtOH–NaOH)/nm
540 (e/dm3mol−1cm−1 4600), 403 (8400), 329 (4000), 283 (sh)
(5400), 262 (10100), 218 (br) (18600); 1H NMR (d6-DMSO,
600 MHz) see Table 1; 13C NMR (d6-DMSO, 150 MHz) see
Table 1; ESI(+)MS m/z 381 (M + H); ESI (−) MS m/z 379 (M–
H); HRESI(+)MS m/z 403.1520 (M + Na, C23H24O5Na requires
403.1521).
Phenol A (2). Identified by spectroscopic analysis. ESI( )MS,
1H NMR and 13C NMR were in good agreement with literature
values.17,18
Phenol A acid (6). Identified by spectroscopic analysis. [a]D,
ESI( )MS, 1H NMR and 13C NMR were in good agreement with
literature values.16–18
Dicitrinin B (12). A red solid; UV-vis kmax(MeCN–H2O)/nm
408 (e/dm3mol−1cm−1 9200), 281 (7300), 267 (6500), 241 (10000);
dH(600 MHz, d6-DMSO) 9.81 (brs, OH), 6.29 (s, H-7), 5.01
(q, J 5.9, H-3), 4.57 (dq, J 6.4, 4.2, H-3ꢀ), 3.29 (obs, H-4ꢀ), 3.24 (q,
J 6.8, H-4), 2.34 (s, H3-11), 1.32 (d, J 6.4, H3-9ꢀ), 1.28 (d, J 6.9,
H3-10ꢀ), 1.27 (d, J 5.9, H3-9), 1.21 (d, J 6.8, H3-10); ESI(+)MS
m/z 787 (2M + Na), 383 (M + H); ESI(−)MS m/z 381 (M–
H); HRESI(+)MS m/z 383.1495 (M + H, C22H23O6 requires
383.1495).
Dihydrocitrinone (7). Identified by spectroscopic analysis. [a]D,
ESI( )MS, 1H and 13C NMR were in good agreement with
literature values.15,25
Dihydrocitrinin (8). Identified by spectroscopic analysis. [a]D,
ESI( )MS, 1H and 13C NMR were in good agreement with
literature values.19
This journal is
The Royal Society of Chemistry 2006
Org. Biomol. Chem., 2006, 4, 1520–1528 | 1527
©